MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Latest
10.48%
↑ 5543% vs avg
Percentile
P86
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
0.19%
Historical baseline
PeriodValue
Q3 202510.48%
Q2 20253.94%
Q1 20255.76%
Q4 202414.00%
Q3 2024-38.88%
Q2 202416.22%
Q1 2024-0.48%
Q4 2023-0.22%
Q3 2023-2.98%
Q2 2023-13.61%
Q1 2023-20.44%
Q4 2022-33.43%
Q3 2022-0.43%
Q2 2022-4.55%
Q1 2022-13.61%
Q4 2021-17.50%
Q3 20210.00%
Q2 2021100.00%
Q1 20210.00%
Q4 20200.00%
Q3 20200.00%
Q2 20200.00%
Q1 20200.00%